|
C11ORF84 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.751500E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.09679999999946E-05 |
| Normal-vs-Stage2 |
1.729810E-02 |
| Normal-vs-Stage3 |
2.461400E-01 |
| Normal-vs-Stage4 |
6.321800E-02 |
| Stage1-vs-Stage2 |
7.118600E-01 |
| Stage1-vs-Stage3 |
6.118700E-03 |
| Stage1-vs-Stage4 |
3.991200E-01 |
| Stage2-vs-Stage3 |
1.304030E-01 |
| Stage2-vs-Stage4 |
7.281200E-01 |
| Stage3-vs-Stage4 |
2.886000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.386900E-04 |
| Normal-vs-AfricanAmerican |
1.974560E-01 |
| Normal-vs-Asian |
7.819200E-03 |
| Caucasian-vs-AfricanAmerican |
6.090200E-01 |
| Caucasian-vs-Asian |
6.043800E-01 |
| AfricanAmerican-vs-Asian |
4.755200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.175700E-03 |
| Normal-vs-Female |
7.406400E-04 |
| Male-vs-Female |
9.307200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.78219999999297E-05 |
| Normal-vs-Age(41-60Yrs) |
5.019500E-03 |
| Normal-vs-Age(61-80Yrs) |
1.591580E-01 |
| Normal-vs-Age(81-100Yrs) |
3.333200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.091990E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.060500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.224600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.864800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.678400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.133200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.120100E-03 |
| Classical-VS-Follicular |
2.474500E-02 |
| Classical-VS-Other |
5.186800E-01 |
| Classical-VS-Normal |
2.35949999999319E-05 |
| Tall-VS-Follicular |
1.844180E-01 |
| Tall-VS-Other |
6.251600E-02 |
| Tall-VS-Normal |
7.806200E-01 |
| Follicular-VS-Other |
2.035000E-01 |
| Follicular-VS-Normal |
1.233760E-01 |
| Other-VS-Normal |
1.817240E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.238650E-03 |
| Normal-vs-N1 |
7.476000E-02 |
| N0-vs-N1 |
4.537600E-01 |
|
|
